Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.15
Bid: 21.15
Ask: 21.50
Change: 0.60 (2.92%)
Spread: 0.35 (1.655%)
Open: 20.55
High: 21.15
Low: 20.55
Prev. Close: 20.55
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Dec 2013 07:00

RNS Number : 5658V
Allocate Software PLC
16 December 2013
 



16 December 2013

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

First Half Trading Update

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, reports the following update for the six months ended 30 November 2013.

 

Allocate's performance in the first half year is in line with the Board's expectations, with total revenue, recurring revenue and pipeline growing versus the first half of the prior year, in what remains the seasonally slower period of our financial year.

 

Closing net cash has risen to £7.4m versus £2.1m at half year end of the prior year.

 

Healthroster continues to lead our business with a better than expected performance in the period. We secured an additional four new customers, including three new NHS Trusts taking the total to 154. These three wins included two competitive displacements. In addition, we renewed a further ten Healthroster term licence customers, bringing the total now to 43 and maintaining our 100% renewal rate.

 

The adoption of the Allocate Cloud continues to increase and is in line with our target of doubling the number of Cloud customers by the end of this financial year.

 

Our latest application, Safe Care, has been well received by NHS Trusts with a number of customers agreeing contracts in the period.

Our Patient Flow and Emergency Department business has not grown at the speed that management expected. Whilst the product has been well received by a number of potential customers, decision cycles are longer than expected.

Our Swedish business continues to perform ahead of management's plans and our Australia business has met expectations, in terms of results and also pipeline. Maritime and Defence had a first half focused primarily on business development activities, as expected.

 

We are pleased to have concluded the rationalisation of our London premises to a single head office and the relocation of our Swedish subsidiary's main office in the period. An exceptional cost will be recorded in the period in respect of these moves.

 

The Company's results for the half year to 30 November 2013 will be released on 20 January 2014.

 

Ian Bowles, Chief Executive Officer of Allocate, commented:

 

"The first half saw another solid performance from Allocate.

 

The demand for our productsremains healthy, particularly with respect to HealthRoster, the Allocate Cloud and Safe Care. We exited the half year with a larger pipeline for these solutions than we had at the beginning of this financial year and significantly stronger than at the same time last year.

 

The focus of the Secretary of State for Health, NHS England and the Care Quality Commission on safe staffing is a key driver of the increasing number of Trusts expressing interest in our solutions, particularly Safe Care.

 

I expect the positive trend we are seeing to continue through the second half of this year. The transition of our customer base onto V10 is a key requirement for growth in sales of Safe Care and Cloud and I am pleased to report that this program continues to be on track.

 

Although the timing of our licence and services revenues remains weighted to the latter part of the year, our strong product portfolio, sales pipeline and the improving quality of our revenue streams give us confidence in a strong second half performance."

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Matt Dixon, Chris Lane

Tel : +44 (0) 20 7831 3113

 

 

About Allocate Software plc

Allocate Software is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

The experience and in-depth knowledge gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi-disciplinary groups, across diverse locations.

 

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUOUWROAAUAAA
Date   Source Headline
2nd May 20247:00 amRNSApproval to List on the Ghana Stock Exchange
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.